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Abstract : The biological liquids matrixes influence on the characteristic masses and repeatability of Pt and Pd 
electrothermal atomic absorption spectroscopy (ETAAS) determination  was studied. The chemical modifiers 
dimethylglyoxime  and  ascorbic  acid  for  matrix  interferences  elimination  and  ETAAS  results  repeatability 
improvement were proposed while bioliquids ETAAS analysis, and their action mechanism was discussed. 
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Introduction 
 
Platinum- and palladium-based preparations  like carboplatin, ephazole, etc. are widely 
used in medicine due to their efficient antiradiation and antitumor activity. 
An urgent task is investigation of these preparations (by Pt and Pd content) distribution in 
the subcellular structures of tumor cells and blood corpuscles of patients. 
However determination of Pt and Pd content in bioliquids (whole blood and blood serum, 
urine,  lymph,  ascitic  fluid,  etc)  by  atomic  spectroscopy  techniques  involves  sample  acid 
rupture, organic matrix destruction, and preliminary separation and preconcentration of Pt and 
Pd [1-10]. 
While  electrothermal  atomic  absorption  spectroscopy  (ETAAS)  technique  features  the 
sensitivity required to determination of Pt and Pd trace amount in human bioliquids, there is 
some sacrifice of measurements accuracy due to significant matrix interferences [11, 12]. 
The goal of the present study is a search of efficient chemical modifiers for matrix effects 
elimination in Pt and Pd determination in bioliquids and development of the direct procedure 
(without preliminary sample preparation) for their determination in blood serum. 
 
Experimental Section 
 
Apparatus 
 
Platinum  and  palladium  determination  was  carried  out  with  atomic  absorption 
spectrophotometer Saturn 3 equipped with electrothermal  atomizer Grafit-2 and deuterium Mediterr.J.Chem., 2012, 2(2),  А. Alemasova et al.  417 
 
 
background  corrector.  Sampling  was  performed  with  Unipipette P 200  device  with  an 
accuracy within ±0.4%. Elements absorbance was monitored at the resonance wavelengths 
265.9 nm (Pt) and 247.9 nm (Pd). The solution tested were sampled out on the pyrolytic 
coated  graphite  platforms  produced  by  OKBA  (Severodonetsk,  Ukraine).  The  source  of 
resonance  emission  was  hollow-cathode  lamps  from  CORTEC  Ltd.  (Moscow,  Russia). 
Heating of the furnace was performed by a 4-step program  after preliminary temperature 
optimization at the pyrolysis and atomization stages. Inert gas was “highest-grade” argon. 
Platinum(IV)  complexes  thermal  destruction  studies  were  performed  with  Q-1500D 
derivatograph  Paulik-Paulik-Ergey  system  (operating  conditions:  dynamic  mode,  air 
atmosphere,  temperature  range  20-800°С)  in  the  covered  alundum  crucibles.  Chemical 
composition of the platinum dimethylglyoximate pyrolysis products was determined using x-
ray phase difractometer Dron 2. 
 
Reagents and standard solutions 
 
All  reagents  were  of  analytical  or  higher  grade.  Standard  solutions  of  H2PtCl6  and 
H2PdCl4 were prepared from the certified reference materials that were donated by Phisico-
Chemical  Institute  of  National  Academy  of  Science  (Odessa,  Ukraine).  Commercial 
Carboplatin from Ebewe Pharma (Austria) was used without additional purification. 
 
Procedure 
 
Standard solution of Pt(IV) (252 μg/L), Pd(II) (25 μg/L) or Carboplatin was sampled into 
the volumetric test tube of 10 mL capacity and the ethanolic solutions (dimethylglyoxime and 
diphenylcarbazone)  or  aqueous  solutions  (chromazurole  S,  ascorbic  acid,  hydrazine 
hydrochloride  or  diantipyrylmethane)  of the modifiers were then  added.  Pig blood  serum 
(1.0 mL) prepared by blood centrifugation at 3000 rps/min during 15 min was added to the 
mixture,  diluted  with  water  to  the  total  volume  of  3.0  mL  and  stirred.  A  portion  of  the 
resulting  solution  (20  μL)  was  sampled  out  on  L’vov  platform  into  the  graphite  furnace 
followed by the atomizer heating under optimum conditions. The modifies efficiency was 
judged  from  characteristic  masses  m0,  i.e.,  the  analyte  masses  producing  an  integrated 
absorbance of 0.0044, and relative standard deviation Sr of absorbance data. 
 
The characteristic masses (m0) were calculated by the formula: 
A
V C
m
0044 . 0
0
 
 , 
where  C  –  analyte  solution  concentration;  V  –  solution  volume;  A  –  integrated 
absorbance value. 
 
 
Results and Discussion 
 
Selection of optimal time-temperature heating program 
 
Optimum  temperature-time  heating  regime  in  platinum  and  palladium  ETAAS 
determination  was  established  by  simulation  of  thermodynamic  parameters  of  high-
temperature evaporation, pyrolysis and free atoms formation processes of the platinum(IV) Mediterr.J.Chem., 2012, 2(2),  А. Alemasova et al.  418 
 
 
and  palladium(II)  compounds  in  the  graphite  furnaces  using  program  package  HSC 
CHEMISTRY 4.0. 
Data of the computer simulation were summarized as the temperature dependencies of 
metals different forms (in kmol) in the condensed and gas phases of the analytical zone – 
graphite tube of the electrothermal atomizer. 
Figures 1 and 2 give the simulation results for standard solutions of H2PtCl6 and H2PdCl4, 
and medical preparations – carboplatin C6H12N2O4Pt and ephazole C20H32N2O2PdCl4. 
  1 
2 
            a                          b  3 
  4 
Figure 1. Simulation of atomization of platinum (a) 1 – Ptc; 2 – Ptg; 3 – PtCg; 4 – PtClc;  5 
5 – PtCl2c; 6 – PtCl3c; 7 – PtCl4c; and palladium (b) 1 – Pdg; 2 – Pdc; 3 – PdOc; 4 – PdCl2c  6 
compounds. Subscript c – condensed phase; g denotes the gas phase.  7 
  8 
     9 
              а                      б  10 
Figure 2. Simulation of carboplatin (a) 1 – Ptc; 2 – Ptg; 3 – PtCg and ephazole (b) 1 –  11 
Pdg; 2 – Pdc; 3 – PdOc atomization. Subscript c – condensed phase; g – gas phase.  12 
  13 
The  data  of  fig.  1a  and  2a  show  that  the  thermostable  platinum  carbide  PtC  with  14 
decomposition  temperature  more  than  2600°С  may  form  at  the  temperature  range  1800- 15 
2500°С in graphite furnace gaseous phase. This process may cause the platinum free atoms  16 Mediterr.J.Chem., 2012, 2(2),  А. Alemasova et al.  419 
 
 
amounts decreasing and may be one of the reasons  of depressing matrix influence while  1 
analysis of samples containing great carbon amounts, for example, bioliquids. In the case of  2 
the palladium the carbide compound is not formed under these conditions.  3 
Figs. 1 and 2 revealed that the Pt and Pd free atoms formation in the standard solutions of  4 
Pt- and Pd-containing compounds differ insignificantly. Platinum atomic vapor is formed in  5 
evaporation of the condensed reduced platinum. In the case of palladium, PdO is first formed  6 
in the condensed phase followed by its reduction to free Pd and subsequent evaporation of the  7 
latter. The pyrolysis maximum allowable temperature in standard solutions of platinum and  8 
palladium  evaporation  amounted  to  1800°С  and  1400°С,  respectively,  whereas  those  for  9 
carboplatin and ephazole were somewhat lower (1500°С).   10 
On this basis the drying step was carried out at 110°С during 30 s, atomization step was  11 
carried out at 2800°С at a “gas-stop” mode of operation during 5 s, and the furnace high- 12 
temperature cleaning was carried out at 2900°С within 3 s. Pyrolysis was carried out with  13 
stepwise increasing the temperature to 1800°С (Pt) and 1400°С (Pd) during 80 s.  14 
  15 
Bioliquids matrix effects on platinum and palladium ETAAS determination   16 
  17 
Table 1 gives the experimental characteristic masses m0 and relative standard deviations Sr  18 
for Pt and Pd absorbance in “non-matrix” solutions and bioliquids under optimum conditions.  19 
The standard solutions characteristic masses are close to those available from the literature:  20 
10 pg for palladium [13] and 56 pg for platinum [14].   21 
The  bioliquids  matrixes  decrease  the  sensitivity  in  platinum  and  palladium  ETAAS  22 
determination  by  the  factor  of  1.5-2  and  1.5-4  respectively.  Moreover,  a  considerable  23 
repeatability decrease is observed for both elements.  24 
  25 
Table 1. Effect of bioliquid matrixes on Pt and Pd ETAAS determination  26 
Sample 
Metrological characteristics 
Pt  Pd 
m0, pg 
Sr (n=3; 
 P= 0.95) 
m0, pg 
Sr (n= 4; 
 P= 0.95) 
”No-matrix” solution  65  0.07  10  0.12 
Blood serum  96  0.23  18  0.07 
Ascitic liquid  106  0.14  16  0.09 
Lymphocytes  131  0.29  39  0.20 
  27 
The use of stabilized temperature furnace with a platform eliminates or essentially reduces  28 
matrix interferences providing that chemical modification is an essential part of the procedure.  29 
  30 
Chemical modifiers in Pt and Pd ETAAS determination in blood serum  31 
  32 
ETAAS determination of Pt and Pd in the biological samples conventionally involves such  33 
chemical modifiers as (NH4)2H2EDТА+NH3+NH4H2PO4 [15], ammonia [16], copper sulfate  34 
[17].  35 
In solving a problem of Pt and Pd atomization processes modification an efficiency of  36 
organic  reagents  which  form  stable  complex  compounds  with  Pt(IV)  and  Pd(II)  ions  in  37 
aqueous  solutions  –  dimethylglyoxime,  chromazurol  S,  diphenylcarbazone  and  diantipyril  38 
methane  –  were  used.  Water  solubility  of  sparingly  soluble  modifiers  was  increased  by  39 Mediterr.J.Chem., 2012, 2(2),  А. Alemasova et al.  420 
 
 
addition of 1.3 % (by volume) of ethanol. The modifiers efficiency was evaluated by their  1 
ability to increase the sensitivity and repeatability of ETAAS technique.  2 
Table II  gives  the  results  as  the  ratios  of  characteristic  masses  and  relative  standard  3 
deviations of Pt and Pd experimental analytical signal in pig blood serum samples with and  4 
without modifiers (m0 and Sr) and (m0
M and Sr
M).  5 
  6 
Table II. Efficiency of chemical modifiers in Pt and Pd ETAAS determination in pig blood  7 
serum**  8 
Modifier (0.001 mol/L)  m0/m0
M  m0
st/m0
M  Sr/Sr
M (n = 3; Р= 0,95) 
Platinum 
Dimethylglyoxime *  1.0  1.0  1.5 
Diphenylcarbazone *  0.98  0.69  0.73 
Chromazurol S  0.98  0.69  0.48 
Palladium 
Ascorbic acid  1.5  1.0  2.0 
Hydrazine hydrochloride  0.97  0.71  0.80 
Diphenylcarbazone *  0.86  0.69  0.90 
Dimethylglyoxime*  1.2  1.0  0.98 
Chromazurol S  1.0  0.83  0.88 
Diantipyrylmethane *  0.91  0.80  0.63 
* in water with 1.3% C2H5OH added (by volume)  9 
** three-fold diluted with water   10 
  11 
Biological samples matrixes decrease the Pt and Pd ETAAS determination sensitivity in  12 
comparison with standard solutions, which don’t contain biological matrixes. The degree of  13 
this influence elimination was estimated by Pt and Pd characteristic masses ratio in standard  14 
solutions (without biological matrix) m0
st and in pig blood serum solutions containing matrix  15 
modifier m0
M. The complete elimination of matrix influence (the ratio m0
st/m0
M is close to 1)  16 
and  1.5-fold  and  2-fold  relative  standard  deviation  decrease  for  platinum  and  palladium,  17 
correspondently, are observed only for dimethylglyoxime and ascorbic acid.  18 
At temperatures below 470 K in the crystallization water melts the interaction between  19 
palladium and ascorbic acid takes place that leads to Pd(II) exothermic reduction to metal  20 
[18].  Besides,  in  the  ascorbic  acid  presence  a  precipitate  forms,  so  analyte  compounds  21 
pyrolysis is faster and more complete. Developed surface of the sediment probably leads to  22 
elements evaporation rate increasing. The presence of ascorbic acid in the sample solution  23 
reduces the diffusion of analytes to the peripheral zones of the furnace at the pyrolysis stage  24 
[19].  25 
Effect of dimethylglyoxime is due to change in the mechanism of free atoms formation,  26 
prevention of analyte low-temperature losses and change on character of platinum and/or its  27 
compounds distribution at the surface of the graphite platform. Derivatography studies Pt(IV)  28 
dimethylglyoximate pyrolysis prepared by the standard procedure [20] support this suggestion  29 
(Fig. 3).  30 
Complex pyrolysis proceeds by a stepwise mechanism and is completed at a temperature  31 
as low as 300°С. X-ray diffraction pattern of the ash residue showed that the main reaction  32 
product of the platinum dimethylglyoximate complete pyrolysis is reduced platinum.  33 
Studies  on  the  pyrolysis  intermediate  products  (230°С)  of  platinum(IV)  34 
dimethylglyoximate  by  x-ray  phase  analysis  support  the  stepwise  pyrolysis  nature  of  the  35 Mediterr.J.Chem., 2012, 2(2),  А. Alemasova et al.  421 
 
 
platinum  complex.  At  the  first  stage  of  the  pyrolysis  such  possible  phases  as  1 
[(NH3)2PtOH)]2(NO3)2,  [Pt(NH3)2](NO3)2,  С2H12N4O4Pt,  C4H12N4O8Pt2,  and  PtO2  were  2 
detected. It is known that the radical pyrolysis of the complexes which modifier forms with  3 
analyte, leads  to  the  analyte  chemisorption  at  the graphite surface [21]. This  prevents  its  4 
diffusion to the cold periphery ends of the platform, and result in the better repeatability in  5 
atomization and improvement of the precision of ETAAS determinations.  6 
  7 
Figure 3. Derivatography data on Pt(IV) dimethylglyoximate pyrolysis: 1 – differential  8 
curve of the mass loss; 2 – integral curve of the mass loss  9 
  10 
Pt and Pd ETAAS determination in pig blood serum  11 
  12 
Dimethylglyoxime and ascorbic acid were used as modifiers in direct (without samples  13 
acid rupture) Pt and Pd ETAAS determination in the pig blood serum.  14 
Blood  serum  (2.0 mL)  was  sampled  into  the  volumetric  test  tube  of  volume  10 mL,  15 
solution  of  dimethylglyoxime  (0.8 mL,  0.0075 mol/L  for  Pt)  or  ascorbic  acid  (0.5 mL,  16 
0.3 mol/L for Pd) was added, diluted with distilled water to the total volume of 6.0 mL and  17 
stirred. The portions (20 μL) of the resulting solutions were sampled out on the graphite  18 
platform and integral absorbance was measured under optimum temperature conditions of the  19 
atomizer.  Pt  and  Pd  content  was  calculated  by  the  method  of  standard  calibration  plot.  20 
Calibrating solutions were prepared by dilution of the Pt(IV) and Pd(II) standard solutions.  21 
Lineal range of calibration was from 50 to 400 μg/L for Pt(IV) and from 10 to 50 μg/L for  22 
Pd(II). The blank was made in all experiments.  23 
The  validity  of  the  results  was  verified  by  “added-found”  method.  The  results  are  24 
presented in Table III.  25 
  26 
Table III. Platinum and palladium determination in pig blood serum (n=5; P=0.95)  27 
Element   Modifier  Added (in 
conversion to 
metal, μg/L) 
Found 
С±δ, μg/L  Sr 
Platinum  Dimethylglyoxime  252*  266±15  0.044 
Palladium  Ascorbic acid  25  23±2  0.035 
* added as Carboplatin  28 
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The recovery is + 106% for Pt and 92% for Pd, respectively. Detection limit was found to  1 
be 20 μg/L for platinum and 5 μg/L for palladium  2 
  3 
Conclusion  4 
  5 
To summarize, the direct (without preliminary sample acid rupture) procedure of platinum  6 
and  palladium  determination  in  the  blood  serum  with  the  use  of  dimethylglyoxime  and  7 
ascorbic acid as modifiers was developed. Relative standard deviation does not exceed 0.05.  8 
  9 
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